FDA’s One-Size-Fits-All Covid Booster Plan Needs to Go

If given at the right time, the boosters still decrease the odds of getting severely ill or dying — and any policy going forward has to focus on the people most at risk. But the ideal timing is complicated, and getting more shots isn’t necessarily better. The FDA’s plan, according to early…

#fda #cdc #danbarouch #harvardmedicalschool #johnsonjohnson #clevelandclinic #wesemann #pauloffit